• Rhythm Pharmaceuticals named Manher “AJ” Joshi as chief medical officer, effective Aug. 17.
• Joshi most recently served as chief development officer at Soleno Therapeutics.
• He previously held senior clinical leadership roles at Neurona Therapeutics, Atara Biotherapeutics, Allergan Medical, Synageva, Genzyme.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rhythm Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608170800PRIMZONEFULLFEED9810992) on August 17, 2026, and is solely responsible for the information contained therein.